India to United States: Rifampicin Export Trade Route
India has recorded 56 verified shipments of Rifampicin exported to United States, representing a combined trade value of $26.3M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $470.4K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 70% of total export value with 6 shipments worth $18.4M USD. On the buying side, CLINICAL RESEARCH PRODUCT is the largest importer in United States with $16.8M USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, MACLEODS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Rifampicin corridor is one of India's established pharmaceutical export routes, with 56 shipments documented worth a combined $26.3M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's rifampicin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $470.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with rifampicin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #18 among India's top rifampicin export destinations globally.
On the import side, key buyers of Indian rifampicin in United States include CLINICAL RESEARCH PRODUCT, UPS SUPPLY CHAIN SOLUTIONS, CLINICAL RESEARCH PRODUCT MANAGEMEN and 2 others. CLINICAL RESEARCH PRODUCT is the single largest importer with 3 shipments valued at $16.8M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#18
- Annual growth+17.1%
- Demand growth+16.6%
- Regulatory ease74/100
Top 10 Indian Rifampicin Exporters to United States
Showing top 10 of 4 Indian suppliers exporting Rifampicin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD Avg $3.1M per shipment | 6 | $18.4M | 69.9% |
| 2 | LUPIN LIMITED Avg $165.2K per shipment | 48 | $7.9M | 30.1% |
| 3 | MACLEODS PHARMACEUTICALS LIMITED Avg $7.7K per shipment | 1 | $7.7K | 0.0% |
| 4 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $54 per shipment | 1 | $54 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting rifampicin to United States, ranked by total trade value. The listed exporters are: MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, MACLEODS PHARMACEUTICALS LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED. MACLEODS PHARMACEUTICALS LTD is the dominant supplier with 6 shipments worth $18.4M USD, giving it a 70% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Rifampicin Importers in United States
Showing top 10 of 5 known buyers in United States receiving Rifampicin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rifampicin in United States include CLINICAL RESEARCH PRODUCT, UPS SUPPLY CHAIN SOLUTIONS, CLINICAL RESEARCH PRODUCT MANAGEMEN, CARINA RERNGSAMAI-NHE, TO THE ORDER OF. The largest importer is CLINICAL RESEARCH PRODUCT, accounting for $16.8M USD across 3 shipments — representing 64% of all rifampicin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CLINICAL RESEARCH PRODUCT | 3 | $16.8M | 63.9% |
| 2 | UPS SUPPLY CHAIN SOLUTIONS | 48 | $7.9M | 30.1% |
| 3 | CLINICAL RESEARCH PRODUCT MANAGEMEN | 2 | $1.6M | 6.0% |
| 4 | CARINA RERNGSAMAI-NHE | 2 | $16.7K | 0.1% |
| 5 | TO THE ORDER OF | 1 | $54 | 0.0% |
Top 10 Rifampicin Formulations Imported by United States
Showing top 10 of 43 product formulations shipped on the India to United States Rifampicin route, ranked by trade value
United States imports a wide range of rifampicin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RIFAMPICIN 300MG AND ISONIAZID 150MG TABLETS BNO:NRZ2306B MFG. DT. APR-2023 EXP.DT. MAR-2025 PS: 24X28S — accounts for $16.7M USD across 1 shipments. There are 43 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RIFAMPICIN 300MG AND ISONIAZID 150MG TABLETS BNO:NRZ2306B MFG. DT. APR-2023 EXP.DT. MAR-2025 PS: 24X28S | 1 | $16.7M | 63.5% |
| 2 | RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLx60 CAPS (RIFAMPICIN) | 4 | $1.6M | 6.1% |
| 3 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES RIFAMPICIN 300MG CAPSULES | 1 | $1.6M | 5.9% |
| 4 | PHARMA : RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLx30 CAPS (RIFAMPICIN) | 3 | $723.4K | 2.7% |
| 5 | RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLX60 CAPS (RIFAMPICIN) | 3 | $711.0K | 2.7% |
| 6 | RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) -1BTLX60 CAPS (RIFAMPICIN) | 1 | $516.8K | 2.0% |
| 7 | PHARMA : RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLx60 CAPS (RIFAMPICIN) | 2 | $425.3K | 1.6% |
| 8 | RIFAMPIN CAPSULES 300 MG RIFAMPIN USP300MG RIFAMPICIN - 26304 BTL x 60 CAPS | 1 | $375.5K | 1.4% |
| 9 | RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLx30 CAPS (RIFAMPICIN) | 2 | $335.0K | 1.3% |
| 10 | RIFAMPIN CAPSULES 300 MG RIFAMPIN USP300MG RIFAMPICIN - 45048 BTL X 30 CAPS | 1 | $276.3K | 1.0% |
Showing top 10 of 43 Rifampicin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 15 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's rifampicin exports to United States are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, MACLEODS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $470.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as rifampin capsules 300mg (rifampin usp 300mg) - 1btlx60 caps (rifampicin) and drugs and pharmaceuticals harmless medicines rifampicin 300mg capsules, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CLINICAL RESEARCH PRODUCT is the largest importer with 3 shipments worth $16.8M USD — representing 64% of all rifampicin imports from India on this route.
Route Statistics
- Trade Volume
- $26.3M
- Avg. Shipment
- $470.4K
- Suppliers
- 4
- Buyers
- 5
- Transit (Sea)
- ~27 days
- Annual Growth
- +17.1%
Related Analysis
Reverse Direction
United States → India — Rifampicin (Import)Other Rifampicin Routes
Unlock the Full India to United States Rifampicin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 56 shipments on this route.
Frequently Asked Questions — India to United States Rifampicin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rifampicin to United States?
The leading Indian exporters of Rifampicin to United States are MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, MACLEODS PHARMACEUTICALS LIMITED. MACLEODS PHARMACEUTICALS LTD holds the largest market share at approximately 70% of total trade value on this route.
Q What is the total value of Rifampicin exports from India to United States?
India exports Rifampicin to United States worth approximately $26.3M USD across 56 recorded shipments. The average value per shipment is $470.4K USD.
Q Which ports does India use to ship Rifampicin to United States?
The most active port of origin is SAHAR AIR with 15 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to United States for Rifampicin?
The average transit time for Rifampicin shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Rifampicin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.1% with demand growth tracking at 16.6%. The route is ranked #18 among India's top Rifampicin export destinations globally.
Q How many suppliers are active on the India to United States Rifampicin route?
There are currently 4 active Indian suppliers exporting Rifampicin to United States. The market is moderately concentrated with MACLEODS PHARMACEUTICALS LTD accounting for 70% of total shipment value.
Q Who are the main importers of Rifampicin from India in United States?
The leading importers of Indian Rifampicin in United States include CLINICAL RESEARCH PRODUCT, UPS SUPPLY CHAIN SOLUTIONS, CLINICAL RESEARCH PRODUCT MANAGEMEN, CARINA RERNGSAMAI-NHE, TO THE ORDER OF. CLINICAL RESEARCH PRODUCT is the largest buyer with 3 shipments worth $16.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Rifampicin.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 5 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 56 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
56 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists